As a proof of concept, we tested the effect of BPTES-induced GLS1 inhibition combined with 5-FU-induced TYMS inhibition and showed that NSCLC cell growth was abrogated and that cell death was induced with significant reduction of tumour growth (Figure 7). The gene discussed is GLS; the disease is non-small cell lung carcinoma.